Cargando…
What we do and do not know about managing respiratory disease in pregnancy
Respiratory disorders are common in pregnant women, but their exclusion from clinical trials makes decisions around pharmacotherapy challenging. Developing programmes designed to improve evidence in pregnancy should be a priority for respiratory research. https://bit.ly/3n6aX42
Autor principal: | Kent, Brian D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584564/ https://www.ncbi.nlm.nih.gov/pubmed/36342868 http://dx.doi.org/10.1183/20734735.0161-2022 |
Ejemplares similares
-
Presbyopia: What We Do Know and What We Do Not Know in 2022
por: Grzybowski, Andrzej, et al.
Publicado: (2023) -
Thymic neuroendocrine neoplasms—what we know, what we don’t know, and what to do about it
por: Lang, Matthias, et al.
Publicado: (2023) -
Arterial Stiffness—What Do We Know about It and What Do We Expect from This Biomarker?
por: Reiner, Željko
Publicado: (2022) -
Eosinophilic-Associated Disease Overlap: What Do We Know About It?
por: Kang, Noeul, et al.
Publicado: (2023) -
What Do We Know about Suicide Bereavement, and What We Can Do to Help Suicide-Loss Survivors?
por: Levi-Belz, Yossi, et al.
Publicado: (2023)